Elsan
elsan.careTotal trials
65
Active
29
Phase 3
2
Total enrollment
19,981
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ropivacaine and dexamethasone injection solution | — | — | — | — | — | 1 | |
| Sodium Chloride 0.9% Injection Solution | — | — | — | — | — | 1 | |
| naropeine or chirocaine | — | — | — | — | — | 1 |
Next readouts
- 2024-12
- 2026-09-04
Top conditions
- Cataract2
- Breast Cancer2
- Bariatric Surgery Candidate2
- Prostate Cancer2
- Obesity2
- Quality of Life2
- Virtual Reality1
- Drug Sedation1
Frequently asked questions about Elsan
- How many clinical trials does Elsan have on ClinicalTrials.gov?
- Elsan is listed as the lead sponsor on 65 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Elsan's trials are in Phase 3?
- 2 of Elsan's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Elsan focus on?
- Elsan's most-studied conditions on ClinicalTrials.gov are Cataract, Breast Cancer, Bariatric Surgery Candidate, Prostate Cancer, Obesity.
- When are Elsan's next clinical trial readouts?
- Elsan has 2 upcoming primary-completion readouts tracked here; the soonest is “Rotator Cuff Repair Under Isolated Loco-regional Anesthesia”, expected around 2024-12.